Biosensor-based affinities and binding kinetics of small molecule antagonists to the adenosine A2A receptor reconstituted in HDL like particles

被引:19
作者
Segala, Elena [1 ]
Errey, James C. [1 ]
Fiez-Vandal, Cedric [1 ]
Zhukov, Andrei [1 ]
Cooke, Robert M. [1 ]
机构
[1] Heptares Therapeut, Welwyn Garden City AL7 3AX, Herts, England
关键词
Surface plasmon resonance; G protein-coupled receptor; Residence time; Lipid disc; MEMBRANE-PROTEINS; DISCOVERY; IDENTIFICATION; RADIOLIGAND; DERIVATIVES; NANODISCS; LIGANDS; POTENT;
D O I
10.1016/j.febslet.2015.04.030
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The options for investigating solubilised G protein-coupled receptors (GPCRs) by biophysical techniques have long been hampered by their instability. A thermostabilised adenosine A(2A) receptor expressed in insect cells, purified in detergent and reconstituted into high-density lipoprotein (HDL) particles was immobilised onto a Surface Plasmon Resonance sensor chip. This allowed measurement of affinities and kinetics for A(2A) antagonists with affinities ranging from 50 pM to almost 2 mu M. Compared with other formats, reproduction of affinities, and dissociation and association rate constants are good, reasonable and poor respectively, indicating stabilised receptors in HDL particles are useful for investigating specific aspects of GPCR-ligand interactions. (C) 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1399 / 1405
页数:7
相关论文
共 32 条
[1]   Kinetics of the early events of GPCR signalling [J].
Adamson, Roslin J. ;
Watts, Anthony .
FEBS LETTERS, 2014, 588 (24) :4701-4707
[2]  
Alex A.A., 2012, RSC DRUG DISCOV SER, V13
[3]   Discovery of β2 Adrenergic Receptor Ligands Using Biosensor Fragment Screening of Tagged Wild-Type Receptor [J].
Aristotelous, Tonia ;
Ahn, Seungkirl ;
Shukla, Arun K. ;
Gawron, Sylwia ;
Sassano, Maria F. ;
Kahsai, Alem W. ;
Wingler, Laura M. ;
Zhu, Xiao ;
Tripathi-Shukla, Prachi ;
Huang, Xi-Ping ;
Riley, Jennifer ;
Besnard, Jeremy ;
Read, Kevin D. ;
Roth, Bryan L. ;
Gilbert, Ian H. ;
Hopkins, Andrew L. ;
Lefkowitz, Robert J. ;
Navratilova, Iva .
ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (10) :1005-1010
[4]   Rapid incorporation of functional rhodopsin into nanoscale apolipoprotein bound bilayer (NABB) particles [J].
Banerjee, Sourabh ;
Huber, Thomas ;
Sakmar, Thomas P. .
JOURNAL OF MOLECULAR BIOLOGY, 2008, 377 (04) :1067-1081
[5]   Membrane protein assembly into Nanodiscs [J].
Bayburt, Timothy H. ;
Sligar, Stephen G. .
FEBS LETTERS, 2010, 584 (09) :1721-1727
[6]   Pharmacology and Structure of Isolated Conformations of the Adenosine A2A Receptor Define Ligand Efficacy [J].
Bennett, Kirstie A. ;
Tehan, Benjamin ;
Lebon, Guillaume ;
Tate, Christopher G. ;
Weir, Malcolm ;
Marshall, Fiona H. ;
Langmead, Christopher J. .
MOLECULAR PHARMACOLOGY, 2013, 83 (05) :949-958
[7]   Nanodiscs for immobilization of lipid bilayers and membrane receptors: Kinetic analysis of cholera toxin binding to a glycolipid receptor [J].
Borch, Jonas ;
Torta, Federico ;
Sligar, Stephen G. ;
Roepstorff, Peter .
ANALYTICAL CHEMISTRY, 2008, 80 (16) :6245-6252
[8]   RECONSTITUTION OF RECEPTOR GTP-BINDING PROTEIN INTERACTIONS [J].
CERIONE, RA .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1071 (04) :473-501
[9]   Biophysical Fragment Screening of the β1-Adrenergic Receptor: Identification of High Affinity Arylpiperazine Leads Using Structure-Based Drug Design [J].
Christopher, John A. ;
Brown, Jason ;
Dore, Andrew S. ;
Errey, James C. ;
Koglin, Markus ;
Marshall, Fiona H. ;
Myszka, David G. ;
Rich, Rebecca L. ;
Tate, Christopher G. ;
Tehan, Benjamin ;
Warne, Tony ;
Congreve, Miles .
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (09) :3446-3455
[10]   Discovery of 1,2,4-Triazine Derivatives as Adenosine A2A Antagonists using Structure Based Drug Design [J].
Congreve, Miles ;
Andrews, Stephen P. ;
Dore, Andrew S. ;
Hollenstein, Kaspar ;
Hurrell, Edward ;
Langmead, Christopher J. ;
Mason, Jonathan S. ;
Ng, Irene W. ;
Tehan, Benjamin ;
Zhukov, Andrei ;
Weir, Malcolm ;
Marshall, Fiona H. .
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (05) :1898-1903